Sentiment Trading

ResMed Inc. reports an 8% revenue increase in Q3 2025, driven by strong demand for sleep health products, solidifying its position as a leader in the health care equipment and supplies sector.

ResMed Inc.’s shares surged 5.39% to €199.50 after the company reported an 8% increase in Q3 revenue, driven by strong demand for its sleep health products and strategic initiatives aimed at enhancing shareholder value.